It's time for an annual favorite, the webinar by GRACE and LUNGevity Foundation focusing on highlights in lung cancer from the ASCO conference, the largest cancer meeting of the year.  

Join us on Thursday, July 18th, at 7 PM Eastern, 4 PM Pacific, for an approximately 90 minute program featuring two great guest experts. We'll be featuring Dr. David Gerber, Associate Professor at University of Texas-Southwestern in Dallas, and Dr. Eddie Garon, UCLA Medical Center in Los Angeles.

David Gerber, MD

We'll start with Dr. Gerber covering questions about locally advanced NSCLC, various current treatment options for first line and maintenance therapy, and also some work on maintenance therapy in extensive stage SCLC.

Edward Garon, MD

Dr. Garon will then focus on a wide range of novel therapies, ranging from immunotherapies to second generation ALK inhibitors to a few potentially helpful new targeted therapy approaches that could become useful treatment options in advanced NSCLC.

Following their presentations, we'll open things up for questions about these new areas of research. The content will be available in the form of podcasts a few weeks after the live event, but you'll want to make time to catch up with Drs. Gerber and Garon to learn the key highlights with us at the live program and potentially ask some questions of them afterward.

And it's a free program! So register now!